Leukotrienes mediate murine bronchopulmonary hyperreactivity, inflammation, and part of mucosal metaplasia and tissue injury induced by recombinant murine …

BB Vargaftig, M Singer - American journal of respiratory cell and …, 2003 - atsjournals.org
BB Vargaftig, M Singer
American journal of respiratory cell and molecular biology, 2003atsjournals.org
Interleukin (IL)-13 induces bronchopulmonary hyperreactivity (BHR), eosinophilic
inflammation, and mucus accumulation in the murine airways. To investigate the potential
role of leukotrienes (LT) in mediating these effects, we studied the ability of IL-13 to induce
the expression of 5-lipoxygenase (5-LO), we compared the effects of IL-13 and of various
leukotrienes on different biological parameters and the interference by the 5-LO inhibitor
zileuton (orally, 50 mg/kg, 3 times a day for 3 days), and by some antagonists. The cysteinyl …
Interleukin (IL)-13 induces bronchopulmonary hyperreactivity (BHR), eosinophilic inflammation, and mucus accumulation in the murine airways. To investigate the potential role of leukotrienes (LT) in mediating these effects, we studied the ability of IL-13 to induce the expression of 5-lipoxygenase (5-LO), we compared the effects of IL-13 and of various leukotrienes on different biological parameters and the interference by the 5-LO inhibitor zileuton (orally, 50 mg/kg, 3 times a day for 3 days), and by some antagonists. The cysteinyl (Cys)-LTs LTC4, LTD4, LTE4, and LTB4, (1 μg/d for 3 d, instilled intratracheally) induced BHR, cell recruitment, fibroblast growth, and mucus production and release into the airways. After the intratracheal instillation of recombinant murine (rm) IL-13, Cys-LT increased in the bronchoalveolar lavage fluid (BALF) at 15 min, followed by lower amounts at 3–6 h. Zileuton inhibited LT production in the BALF, eosinophil and neutrophil sequestration in the lungs, and their passage into the BALF. Zileuton and the Cys-LT-receptor antagonist (ra) LY171883 or MK-571, or the LTB4-ra PH-163 (at 3–10, 5–15, and 10 mg/kg, respectively, administered intratracheally), inhibited BHR by recombinant murine IL-13. Airways mucus after recombinant murine IL-13–challenge was reduced by zileuton and by LY171883, MK-571, and PH-163. LT also induced the vascular endothelium remodelling and collagen deposition. Overall, our results demonstrate the major involvement of LT in the effects of IL-13 on the lung.
ATS Journals